ALLMedicine™ Insulin Pumps Center

Mar 18th, 2023 - Despite increasing use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII, insulin pumps) in type 1 diabetes (T1D) in pregnancy, achieving recommended pregnancy glycaemic targets (3.5-7.8 mmol/L or 63-140 mg/...

Feb 12th, 2023 - This paper studies the features of metabolic parameters, diabetic complications and drug therapy of a single-centre cohort of patients with type 1 diabetes (T1DM) or type 2 diabetes (T2DM) in secondary care and tertiary care over a 15-year period....

Feb 11th, 2023 - Aim: To assess long-term efficacy and safety of open-source automated insulin delivery (AID) in children and adults (7-70 years) with type 1 diabetes. Methods: Both arms of a 24-week randomized controlled trial comparing open-source AID (OpenAPS a...

Jan 31st, 2023 - Racial/ethnic inequities have been observed in diabetes care. To measure changes in prevalence of continuous glucose monitoring (CGM) and insulin pump therapy among Medicare Advantage (MA) beneficiaries with type 1 diabetes (T1D) by race/ethnicity...

Jan 15th, 2023 - Continuous subcutaneous insulin infusion by insulin pump is often superior in improving glycaemic control compared with conventional multiple daily insulin injection (MDI). However, whether pump treatment leads to improved pregnancy outcomes in te...

Dec 9th, 2022 - Hypoglycemia in people with diabetes is common, especially in those taking medications such as insulin and sulfonylureas (SU) that place them at higher risk. Hypoglycemia is associated with distress in those with diabetes and their families, medic...

Feb 19th, 2019 - In both adults and children with diabetes, technologies such as continuous subcutaneous insulin infusion using insulin pumps and continuous glucose monitoring can help improve diabetes control, reduce hypoglycaemia and improve quality of life. Acc...

Mar 17th, 2018 - This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical pra...

Dec 21st, 2022 - Since February 2019 the first hybrid closed-loop insulin pump, the Medtronic MiniMed 670G system, has been offered to people with type 1 diabetes in Belgium. Despite previous studies, the impact of these new kinds of insulin pumps on glycemic cont...

Nov 14th, 2022 - Despite increased use of insulin pumps and continuous glucose monitors (CGM) for pediatric type 1 diabetes (T1D) management and research studies showing benefits from the use of these devices, real-world glycemic control among youth with T1D has w...

Nov 9th, 2022 - The DreaMed Endo.Digital is indicated for use by healthcare professionals treating individuals with Type 1 Diabetes (T1D) who use insulin pump or multiple daily injections (MDI) as their insulin delivery therapy and monitor their glucose levels by...

Oct 19th, 2022 - T2D is a condition that combines insulin resistance and relative insulin deficiency. T2D naturally evolves into an increasingly marked insulin deficiency that leads to the need for pancreatic replacement, by administering insulin. Type 1 diabetes ...

Oct 17th, 2022 - The investigators will recruit adolescents with type 1 diabetes age 11-<13 years and one parent to participate in this 24-month study. While this is admittedly a long enrollment time, study commitments following enrollment will be limited to three...

Dec 8th, 2022 - The Endocrine Society has issued an updated clinical practice guideline on the prevention and management of hypoglycemia in patients with diabetes who are at at high risk, addressing the wide variety of treatment advances, such as insulin pumps an...

Sep 28th, 2022 - Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I'm Dr F. Perry Wilson of the Yale School of Medicine. It was 100 years ago when Leonard Thompson, age 13, received a reprieve from a death sentence. Young master Tho...

Sep 21st, 2022 - (Reuters) -The U.S. Food and Drug Administration on Tuesday warned that certain types of insulin pump systems manufactured by Medtronic were vulnerable to cyberattacks and that hackers could potentially hamper insulin delivery by accessing the dev...

Sep 20th, 2022 - The study covered in this summary was published on Research Square as a preprint and has not yet been peer reviewed. Key Takeaways Hypoglycemia problem-solving perception and use of real-time continuous glucose monitoring (rtCGM) appeared to prote...

Sep 7th, 2022 - Among adolescents with new-onset type 1 diabetes, tighter glucose control didn't stave off a decline in endogenous insulin secretion, according to the randomized CLOuD trial. Compared with standard insulin therapy, youth who started on a hybrid cl...